A comparison of visual hallucinations across disorders by Dudley, R. et al.
 
Accepted Manuscript
A comparison of visual hallucinations across disorders
R. Dudley , C. Aynsworth , U. Mosimann , J-P. Taylor ,
D. Smailes , D. Collerton , S. McCarthy-Jones , P. Urwyler
PII: S0165-1781(18)31877-8
DOI: https://doi.org/10.1016/j.psychres.2018.12.052
Reference: PSY 11983
To appear in: Psychiatry Research
Received date: 9 October 2018
Revised date: 6 December 2018
Accepted date: 7 December 2018
Please cite this article as: R. Dudley , C. Aynsworth , U. Mosimann , J-P. Taylor , D. Smailes ,
D. Collerton , S. McCarthy-Jones , P. Urwyler , A comparison of visual hallucinations across dis-
orders, Psychiatry Research (2018), doi: https://doi.org/10.1016/j.psychres.2018.12.052
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service
to our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and
all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 1 
Highlights 
 Visual hallucinations occur to differing degrees across disorders 
 Hallucinations are usually considered as occurring in a single modality 
 We examined hallucinations in people with eye disease, psychosis, and dementia. 
 We found that single modality hallucinations varied in prevalence across disorders 
 Multisensory experiences are more distressing and more likely to be considered real  
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Abstract 
Research into hallucinations typically regards them as single sensory or unimodal 
experiences leading to a comparative neglect of co-occurring multi-sensory 
hallucinations (MSH). People with psychosis who have visual hallucinations (VH) 
report high rates of hallucinations in other senses (auditory, olfactory, tactile).  
However, it is not known if this is similar to other groups who report VH. 
Consequently, this study explored MSH in four different patient groups who all had 
current VH. Archival data from standardised assessments of visual hallucinations in 
people with psychosis (n=22), eye disease (ED) (n=82), Lewy body Dementia (LBD) 
(n=41), and Parkinson’s disease (PD) (n=41) determined the presence of MSH. 
People with psychosis and visual hallucinations reported significantly higher rates of 
MSH (auditory, 73%; tactile, 82%; olfactory/gustatory hallucinations, 27%) than the 
LBD group (auditory, 21%; tactile, 28%; olfactory/gustatory, 6%), ED (auditory, 1%; 
tactile, 11%; olfactory/gustatory, 0%) and PD patients (auditory, 3%; tactile, 8%; 
olfactory/gustatory, 3%). Regardless of diagnostic grouping, participants with MSH 
reported greater conviction that the VH were real, and reported greater distress. 
People with psychosis with VH report high rates of MSH unlike groups of older adults 
with VH. These between group differences in MSH prevalence have implications for 
clinical practice and theory.  
 
Key words:   Visual hallucination; Psychosis; Dementia; Eye disease; 
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1. Introduction 
 
Visual hallucinations (VH), or visions, are defined as visual percepts that are 
experienced when fully conscious but in the absence of the corresponding external 
stimulus (Waters et al., 2014). VH are common in a number of neurodegenerative 
disorders. Up to 93% of people with Lewy body dementia (LBD) report VH (Ballard et 
al., 1997), as do up to 75% of people with Parkinson’s disease (PD; Barnes & David, 
2001; Williams, Warren & Lees, 2008). People with eye disease (ED) also often 
report VH (60%, (Graham et al., 2011)). In comparison, VH are less common in 
psychosis (27%, (Waters et al., 2014)).  For people with psychosis, auditory 
hallucinations (AH) are much more common (Bracha et al., 1989) than VH. For 
instance, McCarthy-Jones et al., (2017)  reported liftetime prevalence of 64% and 
80% for AH, in two large samples of people with psychosis, whereas prevalence of 
VH was 23% and 30% respectively. The opposite pattern is reported by people with 
neurodegenerative conditions where AH are less frequently reported than VH 
(Ballard et al., 1997, Fenelon et al., 2000).  For instance, Inzelberg et al. (1998) 
reported prevalence of VH in people with PD as 22% to 38% whereas AH were less 
frequent (8%). The reason why both AH and VH are present in such disorders, and 
yet show opposite ratios of prevalence, remains unclear. 
When considering this literature, hallucinations are typically treated as if they 
are separate, discrete sensory experiences occuring in only one distinct modality 
(i.e. unimodal hallucinations). However, hallucinations can occur in more than one 
sensory domain in which instance they are termed multi-sensorty hallucinations 
(MSH) or multimodal hallucinations (MMH).  When people with psychosis are 
specifically asked if they experience a range of hallucinatory phenomena across 
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visual, auditory, tactile and olfactory domains then MMH are often reported. For 
example, Lim et al. (2016) found that lifetime reporting of MMH was twice (53%) that 
of uni-modal hallucinations (27%). Lim et al. (2016) conclude that MMHs are a 
characteristic feature of schizophrenia spectrum disorders. Llorca et al., (2016) 
explored MMH with people with PD (n=100) and people with schizophrenia (n=100).  
When asking about the past week they found a higher prevalence of VH than AH in 
the PD group (88% and 45% respectivley) which was broadly the opposite to the 
schizophrenia group (55% VH and 83% AH).  However, the combination of auditory 
and visual hallucinations was the most frequent for both PD and schizophrenia 
groups. Other than in PD, where they were seemingly commonly reported (Llorca et 
al., 2016), the prevalence of MMH is yet to be explored in other conditions. 
Therefore, this study extends the understanding of MMH across groups of people 
with psychosis, LBD, ED or PD. 
The work reported to date typically considers MMH in terms of the number of 
sensory domains that people report the experiences within but not the nature and 
relationship of these multimodal experiences.  At least two important dimensions of 
MMH have already been identified (Lim et al., 2016). The first is a temporal 
dimension in that MMH may be serial or simulateneous. Serial MMH are 
hallucinations that occur in more than one sensory modality but occur at different 
times.  For example, someone may report seeing a vision of a person, and at a later 
point report hearing a voice of someone speaking but importantly there is a temporal 
difference and the voice does not co-occur with the vision. Simultaneous MMH are 
defined as hallucinations that occur in more than one sensory modality at the same 
time e.g. someone sees a vision of a person whilst also hearing a voice of someone 
speaking. 
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A second potentially important dimension of MMH relates to the attribution of 
the agency or identity of the hallucination. The hallucinations in different modalities 
may be experienced as originating from the same agent/entity (related) or as coming 
from different agents/entities (unrelated). When combined with the temporal 
dimension, this gives four potential possibilities. The first is a simultaneous-related 
MMH. An example of this would be seeing an entity who also speaks. The second is 
a simultaneous-unrelated MMH, which could involve seeing one entity whilst hearing 
a voice recognised as belonging to another entity. Third, there may be serial-related 
MMH. An example of this would be seeing an entity at one time, and then at a later 
time feeling the touch of the (then unseen) entity. Finally, there is the possibility of 
serial-unrelated MMH, such as seeing an entity at one time and then feeling the 
touch of another entity at a later time (Lim et al., 2016).  
In an attempt to consider the multimodal nature of VH, Dudley et al., (2018) 
investigated MMH in people with psychosis using the North East Visual Hallucination 
Interview (NEVHI; (Mosimann et al., 2008)) which allowed exploration of whether the 
experiences were related or not.   Participants who reported having VH were asked 
whether they also had other hallucinations and whether these experiences were 
serial or simultaneous.  Then the identity dimension was ascertained by asking if the 
VH ever spoke to, touched the person etc. Dudley et al., (2018) found that nearly all 
(95%, 21/22) the participants had serial unrelated hallucinations in that they all 
reported  VH and also unrelated AH.  Furthermore, they very often reported VH with 
related hallucinations in other sensory modalities (86%). The most frequent 
combination was of 3 senses; VH that talked to and touched the individuals.  Hence, 
for people with VH in the context of psychosis, their VH were not silent, unimodal 
experiences but were better understood to be multisensory experiences that were 
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seen as related. Understanding the temporal and identity dimensions of multimodal 
hallucinations may have important theoretical and clinical implications.  
In terms of clinical implications, for people with psychosis the presence of VH 
is associated with greater distress, and disability (Mueser et al., 1990). If VH are 
actually better understood as related MMH then it may help explain this impact.  If 
VH have an auditory and tactile component  that are seen to be related it may mean 
that people are more convinced that the experience is real and this greater 
conviction may lead to greater distress (Collerton and Dudley, 2004).   
Besides clinical utlilty, understanding the nature of mulitisensory experiences 
could have important theoretical implications.  Having established the relatedness of 
MMH in people with psychosis the aim of the present study was to explore the 
prevalence of related MMH across groups of people with psychosis, LBD, ED and 
PD which are conditions defined by the high prevalence of VH. The work 
purposefully takes a transdiagnostic approach to understanding and describing VH.  
This is consistent with the NIMH Research Domain Criteria (RDoC; (Cuthbert and 
Insel, 2013)), which suggests that our understanding of hallucinations might be 
enriched by moving beyond the confines of categorical diagnoses and incorporating 
what is known about hallucinations across populations/diagnoses (Ford et al., 2014). 
It could be that related MMH are the result of a general proneness to hallucinations 
(van der Gaag, 2006) whereas unimodal or unrelated MMH experiences may rely on 
domain specific processes (Collerton et al., 2005).   
 Therefore, this study explored in more detail whether people with VH in the 
context of ED, PD, DLB, or psychosis report MMH.  Specifically, the aim was 
determine the prevalence and impact of related multimodal hallucinations.  The work 
was purposefully exploratory and largely descriptive and drew on existing, archival 
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data sets. The focus of the work was on the identity dimension and to what extent 
people with VH in these different conditions report related hallucinatory experiences 
which has not been previously considered across these disorders.   
2. Method 
2.1 Participants 
Four groups of people who all reported VH participated, consisting of 82 
people with Eye Disease (27M, 55F) aged between 57-99 (M=80.07, SD=8.13), 41 
with Parkinson’s disease (21M, 20F) aged between 52-89 (M=72.63, SD=9.48), 31 
with Lewy Body Dementia (20M, 11F) aged between 61-89 (M=77.65, SD=7.58) and 
22 people with psychosis (12M, 10F) aged between 19-34 (M=24.3, SD=4.03). Total 
sample size was 176. 
Participants met inclusion and exclusion criteria for the original study that their 
data are derived from and are described in the original published articles (Dudley et 
al., 2018,  Makin et al., 2013, Mosimann et al., 2008, Taylor et al., 2011, Urwyler et 
al., 2014).   
Participants were free from significant hearing impairment and provided 
informed consent. PD and LBD patients were only included if they had no visual field 
defects on neurological examination. Data was only included if people reported VH 
within the last month of data collection. This excluded a further 136 participants from 
original studies as they did not report current VH experiences.  
 
2.2 Measures 
The North East Visual Hallucination Interview (NEVHI; Mosiman et al., 2008) 
was completed by all the participants. This is a 20 item semi-structured interview that 
assesses the phenomenology of VH and its emotional, social and behavioural 
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impact. The NEVHI specifically explores related MMH by asking how people’s 
visions interact with other sensory modalities, such as auditory experiences - “Do 
your hallucinations ever speak or make noises?”, olfactory/taste experiences - “Are 
your hallucinations ever associated with an odd taste or smell?”, and tactile 
experiences- “Does it ever feel like your hallucinations are touching you?”.  The 
NEVHI also addresses the emotional impact of VH asking whether VH are 
“distressing or frightening”, and “frustrating and irritating” rated on a three point scale 
(0=never, 1=sometimes, 2=always).  The interview also rates people’s appraisals of 
the VH by asking “When you are having a hallucination do you ever believe that it is 
real?”. For each study the NEVHI was administered by experienced 
clinicians/researchers. The measure has high internal consistency (α=.71) and good 
inter-rater reliability (κ=.83). 
The following measures were used with the ED, PD and LBD groups but not 
with the people with psychosis. Binocular best visual acuity expressed in decimals 
(i.e. 1.0 vision=100% vision; equals to 6/6 vision), was examined at a test distance of 
40 cm (Hohmann and Haase, 1982). The Mini Mental State Examination (MMSE) 
(Folstein et al., 1975) was used to assess cognition.  To assess executive and 
language skills the verbal fluency (FAS test) and category fluency test were 
administered (Lezak et al., 2004). The severity of motor features and the impairment 
in functional activity were assessed using the Unified Parkinson’s disease rating 
scale (UPDRS) part II and part III, respectively (Jenkinson et al., 1997). The Epworth 
Sleepiness scale (ESS) was used to assess day- time sleepiness (Johns, 1991). The 
Mayo sleep questionnaire (Boeve et al., 2002) was used to determine the presence 
of rapid eye movement (REM) sleep behaviour disorder (RBD) symptoms.  
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2.3 Data analysis 
 Group differences in the prevalence, emotional response to the VH, and the 
conviction that the VH was real were compared using appropriate categorical 
analyses (Chi square and Fisher exact tests). In addition to disorder group 
comparisons the data was clustered according to whether people reported unimodal 
or multimodal experiences based on whether participants endorsed the 3 questions 
asking about auditory, tactile or olfactory/gustatory experiences (that co-occur with 
their vision).  Participants who scored either a “1=sometimes” or “2=always” on any 
of those questions where considered to have related MMH. This grouping variable 
was used to compare NEVHI responses for emotional responses and conviction. If 
people endorsed the questions as a 1 or above, it was rated at a “yes/present”, 
whereas those scored 0 were classified as a “no”.  
 
2.4 Ethical considerations 
The data from the NEVHI was collected as part of the primary research studies 
referenced above, all of which were approved by NHS Ethics committees and were 
registered with the local NHS trust research and development department. All 
participants gave informed consent to participate in the original research.  As the 
data was subject to a secondary analysis not identified at the time consent was 
gained, permission to use this data was sought from an NHS ethics approval 
committee.  The authors assert that all procedures contributing to this work comply 
with the ethical standards of the relevant national and institutional committees on 
human experimentation and with the Helsinki Declaration. 
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3. Results 
  
3.1 Missing data 
Given the presenting difficulties in older adult populations, not all of the questions 
on the NEVHI were completed. For the psychosis group, all data was collected. 
Owing to the preliminary state of the research, participants with missing data were 
omitted which accounts for the variations in sample size for each question answered.  
 
3.2 Demographics 
Table 1 summarizes the demographics and clinical characteristics.  As 
expected, the groups differed in age, in that the people with psychosis were younger 
than the other groups.  The ED group differed from the PD group in age.  Also, the 
ED group had the lowest visual acuity score. The LBD group had significantly lower 
scores in all cognitive measures (MMSE, verbal fluency, and categorical fluency) and 
significantly higher UPDRS and ESS scores compared with other groups.  
 
Table 1 about here please 
 
3.3 Prevalence of related MMH  
Table 2 indicates how commonly people with VH also report related tactile, 
auditory or olfactory/gustatory experiences.  As can be seen, related MMH were very 
common in people with psychosis who report VH (86.4%). In contrast, they were rare 
in people with VH in the context of ED (3.7%) and PD (10.3%). Those with LBD 
reported intermediate rates (32.1%) of related MMH.  
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 Group comparisons using Fisher exact test indicated differences between the 
groups for all three sensory domains (as noted in Table 2). Further crosstab analysis 
demonstrated that differences in the prevalence of related tactile and visual MMH in 
those with ED and neurodegenerative conditions were not significant; whereas the 
PD group reported lower levels of related tactile and visual MMH than did the LBD 
group. People with psychosis reported significantly more tactile and visual MMH than 
the other three groups.  
 In terms of the prevalence of related auditory and visual MMH, the difference 
between the ED and PD groups was not significant. The LBD group reported 
significantly higher levels of related auditory and visual MMH than the ED group 
(p<0.001) and the PD group (p=0.013). People with psychosis reported significantly 
higher levels of related auditory and visual MMH than the other three groups. 
Table 2 about here please 
 
The prevalence of related olfactory/gustatory and visual MMH was higher in 
the psychosis group than in the than in the PD group (p=0.004). No other group 
differences were significant.   
 
3.4 Emotional response to and Conviction in VH (MMH) 
Table 3 reports participant’s ratings of their emotional reactions to seeing their 
visions and their belief that their visions are real according to whether people 
reported unimodal or MMH. Participants with MMH were significantly more likely to 
rate their VH as irritating (p=.000), more distressing (p=.000), and more likely to 
report belief in their VH as being real (p=.014).  
 
Table 3 about here please 
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4. Discussion 
 This study explored related multimodal hallucinations (MMH) across groups of 
people with psychosis, Lewy Body Dementia (LBD), eye disease, (ED) and 
Parkinson’s disease (PD) all of whom reported visual hallucinations (VH). Related 
MMH were much more common in psychosis than in PD, ED, with DLB rates being 
intermediate.  People who experienced related MMH were more distressed, 
frustrated and expressed stronger conviction that the VH was real than those 
experiencing unimodal hallucinations.  
 These findings, and those of previous research on MMH suggest a need for 
models that can account for both unimodal and multimodal hallucinations.  Previous 
research has indicated that people with PD and DLB report much higher levels of VH 
than AH (Inzelberg et al., 1998) which is the opposite pattern to people with 
psychosis who report higher rates of AH than VH (McCarthy-Jones et al., 2017).  
Such findings may suggest domain specific explanations for these unimodal 
experiences.  However, MMH are more common than unimodal hallucinations in 
people with PD and people with psychosis (Llorca et al., 2016) in that people report 
hallucinations in a number of sensory domains.  Hence, models need to explain 
these multimodal experiences perhaps by proposing a common hallucinatory 
process that leads to hallucinations across a number of domains.  However, given 
the differing prevalence rates of AH and VH, it may still be possible that there are 
modality specific processes and that people are affected separately in two or more of 
these sensory domains at least when accounting for serial unrelated hallucinations.   
However, the present research indicated that people with VH across a range of 
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disorders, differed in rates of simultaneous related MMH.  In particular, when people 
with psychosis report VH it is very likely that they will be experienced as MMH with 
their visions also talking to and touching them.   Whilst single sensory experiences 
like only having VH (as in ED) or only having AH (as in many people with psychosis) 
may be accounted for with domain specific unimodal explanations (Collerton, et al., 
2005) where people report multimodal experiences these may need to be explained 
by different mechanisms.   
Recently it has been proposed that hallucinations may be understood within a 
generative model of perception (Friston, 2010). In this account prior experiences are 
combined with observed sensory data within a hierarchical neural system to reduce 
perceptual errors (Sterzer et al., 2018).  In effect the decision about whether an 
experience is real or imagined arises from a combination of: i) the quality of the 
sensory data that people are relying on which can be degraded owing to perceptual 
impairments as is obviously the case for people with eye disease; ii) a judgement 
about the source of the material which can be affected by a bias towards external 
sources as revealed in people with psychosis by their performance on reality 
monitoring (Aynsworth et al., 2017) and reality discrimination tasks (Bristow et al., 
2014); iii) and the role of expectation or prior beliefs (Sterzer et al., 2018). To some 
extent the groups investigated in this current study may differ in the degree to which 
the quality of the data, the judgement process, and expectation may play a role in 
the experience of VH.  
Such predictive coding models seem well suited to explaining the co-
occurrence of symptoms like hallucinations and delusions in people with psychosis, 
and may be valuable in understanding these related MMH. Our findings show that 
older people with visual perceptual impairments (ED) or those with intact cognitive 
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processes (PD), report very low rates of related hallucinations. With the older adult 
groups as cognitive impairment increases there is a greater likelihood of reporting 
related MMH (DLB). People with PD and those with DLB have been shown to tend to 
see faces in neutral objects (pareidolia) which implies greater reliance on top down 
processes (Mamiya et al., 2016, Uchiyama et al., 2012, Uchiyama et al., 2015, Yokoi 
et al., 2014). It may be that as people rely more on expectancy to help make sense 
of the ambiguous sensory data where there is greater cognitive impairment it may 
lead to difficulty distinguishing real from imagined.  
However, related MMH are even more common in people with psychosis who 
owing to their much younger age typically have less perceptual impairment and are 
less likely to experience the cognitive problems with attention, concentration and 
memory seen in PD and DLB. Hence, it would seem unlikely that greater perceptual 
and cognitive impairment alone would explain greater related MMH.  People with 
psychosis are reported to be less influenced by past expectancy and are more driven 
by the sensory data (Sterzer et al., 2018). To be consistent with a generative model 
of perception it may be that different processes or combinations of processes 
contribute to the increased rate of reporting of related MMH in people with psychosis 
with VH.  
 Clearly there are a number of limitations that need to be held in mind.   The 
obvious limitation is our use of archival data.  We have previously reported on the 
multisensory nature of VH for the 22 people with psychosis (Dudley et al., 2018) 
used in this present study.  However, we also report entirely new data on 82 people 
with Eye Disease, 41 with Parkinson’s disease and 31 with Lewy Body 
Dementia.  Hence, the previously presented data represents 12.5% of the current 
sample and, of course, the comparison across group is novel. The source studies for 
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the Eye Disease, Parkinson’s and Lewy Body dementia groups did not specifically 
investigate the coexistence of VH with other modalities or the relatedness of MMH. 
However, in the source studies the participants all completed the same assessment 
of VH allowing exploration of the relatedness of MMH. The judicious use of archival 
data is important as it maximises the use of existing data and avoids unnecessarily 
burdening participants with additional measures solely for examining exploratory 
questions.  Of course, the groups differed in diagnosis, and to some extent age and 
gender. However, this is entirely in keeping with a transdiagnostic approach 
(Cuthbert and Insel, 2013) and was used to try and examine similarities and 
differences in VH across these disorders.   
 A key limitation though is that whilst we identified differences in the rates of 
related MMH we were not able to directly test the mechanisms that may potentially 
account for related MMH VH.  Here, the first task was to explore, in detail, the 
relatedness and agency of the VH.  If the groups did not differ in the relatedness of 
the MMH then there would be little to learn from the performance on secondary 
measures. However, having established some apparent differences in the 
phenomena reported, a future investigation of this area could a) systematically 
assess hallucinations across a range of modalities (Lim et al., 2016), b) explore the 
relatedness of these phenomena (Dudley et al., 2018), c) explore cognitive and 
perceptual abilities as well as testing reality discrimination, reality monitoring, and top 
down processing using pareidolia type tasks, as well asking about imagery 
(Aynsworth et al., 2017) and trauma history (Solsevik et al., 2016).   
A further limitation is that owing to the amount of missing data we could have 
underestimated the prevalence of related MMH in the older adult groups. Whilst 
possible, it is important to note the high response rate on the AH question (130/137) 
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for the older adult’s groups.  This is likely to be a commonly experienced 
hallucination in addition to VH, but we still see very little reporting of AH.  Therefore, 
it is possible that the participants were not experiencing other undetected related 
hallucinatory phenomena.  
 It is possible that people reported unrelated hallucinations, perhaps hearing a 
voice or a sound that was not related to the vision.  These would be multimodal 
hallucinations as well, but would be considered unrelated hallucinations, and we 
would assume would be temporally unrelated as well.  This information was collected 
for the psychosis group (and 21 of the 22 also reported other AH experiences, 
Dudley et al, 2018) but not for the other groups. Previous studies of people with VH 
in the context of ED, DLB and PD have asked systematically about the presence of 
AH or hallucinations in other modalities and reported that they are much less 
common than VH (Ballard et al., 1997, Fenelon et al., 2000), so whilst we may have 
missed these experiences they are not likely to have been as common as in people 
with psychosis.   
 It is striking that VH for most of the participants, with the exception of the 
psychosis sample, are not reported as MMH.  Of course, reporting of VH is less 
frequent than AH in people with psychosis.  AH are generally reported as unimodal 
experiences (McCarthy-Jones et al., 2017), so we may be examining a somewhat 
different set of processes in people with psychosis and VH than those with 
Psychosis and AH.  
 We found that that there were higher levels of distress, and conviction in 
those people with MMH.  However, this grouping was largely composed of people 
with psychosis, who may for other reasons besides the nature of their hallucinations 
report more distress and conviction.  Whilst the questions were related to the 
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distress of seeing the vision, clearly, future research with larger groups of 
participants (including Alzheimer Dementia, non-clinical populations) could consider 
if multimodality rather than diagnosis is most indicative of distress and conviction.  Of 
course, other factors such as the content, frequency, persistence and appraisals of 
what it means to see visions (Dudley et al., 2012) may all also play a role in the 
distress and conviction reported (Thomson et al., 2017). 
Possible clinical implications of this work are that a brief normalising rationale 
that explains that visions are common, and are a result of impaired perceptual 
processes may be helpful and reduce distress in people with ED, or PD.  Where 
there is cognitive impairment or particularly in people with psychosis, where 
multimodality is common and conviction and distress are high, it may be that 
normalisation alone may be insufficient and a number of reality testing approaches 
are needed to help the person learn that their vision cannot cause them harm, and 
that they are safe (Wilson et al., 2016). 
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TABLE 1. Clinical and demographic characteristics (n = 176)  
 ED n 
= 82 
PD n = 
41 
LBD n = 
31 
Psychosis 
n = 22 
Statistics P 
Age (years) 80.07 
(8.13) 
72.63 
(9.48) 
77.65(7.58) 24.41 
(4.58)  
F=288.713
Z
,
 
20.447
A
, 2.079
B
, 
5.832
C
 , 945.713
D
, 
503.154
E
, 
858.517
F
 
<0.001
Z,A,D,E,F
, 
0.152
B
, 0.018
C
 
Female (%) 55 
(67.1) 
20 
(48.8) 
11 (35.5) 12 (54.5) χ
2
=10.240
Z
, 3.84
A
, 
9.24
B
, 1.27
C
, 
1.19
D
, 0.19
E
, 1.90
F 
0.017
Z
, 0.05
A
, 
0.002
B
, 
0.259
C
, 
0.276
D
, 
0.663
E
, 0.168
F
 
Education (years) 10.66 
(2.25) 
10.24 
(3.18) 
10.08 
(1.32) 
n.a F =0.557
Z
,
 
0.697
A
, 
0.818
B
, 0.034
C
 
0.574
Z
, 
0.406
A
, 
0.368
B
, 0.855
C
 
Visual acuity 
(decimals) 
0.152 
(0.169) 
0.370 
(0.131) 
0.318 
(0.144) 
n.a
 F =28.246
Z
, 
52.276
A
, 9.686
B
, 
1.292
C 
<0.001
Z,A
, 
0.002
B
 , 
0.261
C
 
MMSE [max = 
30] 
27.33 
(1.71) 
) 
26.95 
(3.14) 
20.52 
(4.12) 
n.a F =73.171
Z
, 
0.760
A
, 154.103
B
, 
56.627
C
 
<0.001
Z,B,C
, 
0.385
A
 
Verbal fluency 
(words per 
minute) 
12.57 
(5.58) 
12.26 
(5.89) 
6.11 (4.56) n.a F =3.568
Z
, 0.069
A
, 
7.47
B
, 5.97
C
 
0.032
Z
, 
0.793
A
, 0
.
008
B
 
,0.019
C
  
Categorical 
fluency (animals 
per minute) 
14.92 
(4.04) 
15.88 
(5.91) 
9.20 (3.45) n.a F =12.826
Z
, 
0.497
A
, 24.830
B
, 
21.785
C
 
<0.001
Z,B,C
, 
0.483
A
 
Parkinsonism 
duration (years) 
n.a  8.32 
(4.27) 
3.75 (3.28) n.a.
 F =11.657
C 
0.001
C
 
UPDRS Motor 
[max = 67] 
n.a 24.39 
(11.62) 
27.88 
(15.67) 
n.a
 F =1.831
Z
, 0.877
C
 0.170
Z
, 0.353
C
 
ESS [max = 24] 5.5 
(0.71) 
8.71 
(5.62) 
12.50 
(0.71) 
n.a
 F =0.818
Z
, 0.636
A
, 
98.0
B
, 0.889
C 
0.448
Z
, 
0.430
A
, 
0.010
B
, 0.351
C
 
RBD likely (%) 1 (1) 13 
(31.7) 
9 (45) n.a χ
2
=1.19
Z
, 0.291
A
, 
0.018
B
, 1.03
C 
<0.001
Z
, 
0.550
A
 0.714
B
, 
0.310
C
 
Data are mean and (SD) unless specified otherwise; Statistics are one-way ANOVA (F) or chi-square (χ2) tests or °Fisher’s Exact; MMSE = 
Mini-Mental State Examination, UPDRS = Unified Parkinson’s Disease Rating Scale, ESS = Epworth Sleeping Scale; RBD = Rapid eye 
movement sleep behaviour disorder; ED = Eye disease; PD = Parkinson’s disease; LBD = Lewy body dementia; n.a = not available; Z 
comparison across all groups, df =3; A ED vs. PD, df =1; B ED vs. LBD, df =1; C PD vs. LBD, df =1; D ED vs. Psychosis, df =1; E PD vs. 
Psychosis, df =1; F LBD vs. Psychosis, df =1; 
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TABLE 2. The prevalence of other hallucination modalities in combination with visual 
hallucination across disorders 
 ED n = 
81 
PD n = 
39 
LBD n 
= 28 
Psychosis 
n = 22 
Statistics p 
Unimodal (%) 78 
(96.3) 
35 
(89.7) 
19 
(67.9) 
3 (13.6) χ
2
=92.526
Z
, 113.00
A
, 
97.00
B
, 54.00
C
, 
81.00
D
, 38.00
E
, 
22.00
F 
<0.001
Z,A,B,C,D,E
, 
0.001
F
 
MMH (%) 3 (3.7) 4 
(10.3) 
9 (32.1) 19 (86.4) χ
2
=18.731
Z
, 7.00
A
, 
12.00
B
, 13.00
C
, 
22.00
D
, 23.00
E
, 
28.00
F 
<0.001
Z,E,F
, 
0.029
A
, 0.005
B
, 
0.001
C
, 0.001
D
 
 n = 27
#
 n = 39
#
 n=18
#
 n=22
#
   
Tactile (%) 3 
(11.1) 
3 (7.7) 5 (27.8) 18 (81.8) χ
2
=44.01
Z
, 0.226
A
, 
2.05
B
, 4.12
C
, 
24.747
D
, 34.236
E
, 
11.831
F
 
<0.001
Z,D,E
, 
0.635
A
 , 0.152
B
, 
0.042
C
, 0.001
F
 
 n = 80§ n=39§ n=28§ n=22§   
Auditory 1 (1.3) 1 (2.6) 6 (21.4) 16 (72.7)
 χ
2
=78.39
Z
, 0.274
A
, 
13.93
B
, 6.19
C
, 
63.472
D
, 34.446
E
, 
13.158
F 
<0.001
Z,B,C,D,E,F
, 
0.601
A
, 0.013
C
 
 n = 2¥ n = 39¥ n = 18¥ n = 22¥   
Olfactory (%) 0 (0) 1 (2.6) 1 (5.6) 6 (27.3) χ
2
=10.42
Z
, 0.053
A
, 
0.117
B
, 0.326
C
, 
0.727
D
, 8.453
E
, 
3.234
F 
0.015
Z
, 0.819
A
 
0.732
B
, 0.568
C
, 
0.394
D
, 0.004
E
, 
0.072
F
 
Data are n (%); Statistics are chi-square (χ2) or Fisher’s exact tests; ED = Eye disease; PD = Parkinson’s disease; LBD = 
Lewy body dementia; MMH = multimodal hallucinations 
Z comparison across all groups: df = 3; A ED vs. PD: df = 1; B ED vs. LBD: df = 1; C PD vs. LBD: df = 1; D ED vs. Psychosis, 
df =1; E PD vs. Psychosis, df =1; 
F LBD vs. Psychosis, df =1; # = number of answers to sections corresponding to tactile hallucination; § = number of answers 
to sections corresponding to auditory hallucination; ¥ = number of answers to sections corresponding to olfactory 
hallucination; 
TABLE 3. Emotional response and Conviction towards VH in MMH 
 
 Unimodal 
n = 135 
MMH n 
= 35 
Statistics p 
Type of emotional 
response 
    
Irritating/frustrating (%) 47 (33.3) 30 (78.9) χ
2
=25.407; df=179 <0.001 
Distressing/frightening (%) 46 (32.6) 30 (78.9)
 χ
2
=26.291; df=179
 
<0.001 
Conviction     
Belief VH is real (%) 31 (60.8) 26 (86.7) χ
2
=6.069; df=81
 
0.014 
Data are n (%); Statistics are chi-square (χ2) tests 
 
 
